Cargando…

The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients

BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 separated pulmonary function from combined assessment. We aimed to analyze the characteristics of airflow limitation and future exacerbations in different GOLD groups of chronic obstructive pulmonary disease (COPD) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Qing, Zhao, Yi-Yang, Zeng, Yu-Qin, Liu, Cong, Cheng, Wei, Deng, Min-Hua, Li, Xin, Ma, Li-Bing, Chen, Yan, Cai, Shan, Chen, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143960/ https://www.ncbi.nlm.nih.gov/pubmed/34040367 http://dx.doi.org/10.2147/COPD.S309267

Ejemplares similares

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study
por: Huang, Wei-Chang, et al.
Publicado: (2018)

Combination therapy for airflow limitation in COPD
por: Ghanei, Mostafa, et al.
Publicado: (2012)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD
por: Sun, Tian, et al.
Publicado: (2020)

Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation
por: Grabcanovic-Musija, Fikreta, et al.
Publicado: (2015)

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal
por: Grünewaldt, Achim, et al.
Publicado: (2022)

The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reports
por: Song, Qing, et al.
Publicado: (2023)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
por: Millares, Laura, et al.
Publicado: (2019)

Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation
por: Murphy, Daniel E, et al.
Publicado: (2013)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Effect of Airflow Limitation on Acute Exacerbations in Patients with Destroyed Lungs by Tuberculosis
por: Kim, Soo Jung, et al.
Publicado: (2015)

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2016)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD
por: ASLANI, Mohammad Reza, et al.
Publicado: (2020)

Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death?
por: McDonnell, Melissa J., et al.
Publicado: (2021)

Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation
por: Goërtz, Yvonne M. J., et al.
Publicado: (2019)

Comparative evaluation of expiratory airflow limitation between patients with COPD and BE using IOS
por: dos Santos, Daniele Oliveira, et al.
Publicado: (2021)

Correlations of Computed Tomography Measurement of Distal Pulmonary Vascular Pruning with Airflow Limitation and Emphysema in COPD Patients
por: Tang, Guoyan, et al.
Publicado: (2022)

Not every irreversible airflow obstruction is COPD
por: Baddini-Martinez, José
Publicado: (2016)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
por: Heraganahally, Subash S, et al.
Publicado: (2021)

GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population
por: Kainu, Annette, et al.
Publicado: (2016)

Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Nam Eun, et al.
Publicado: (2023)

Influences of Two FEV(1) Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients
por: Wei, Dafei, et al.
Publicado: (2022)

“Discordant Airflow Obstruction: GOLD versus LLN”
por: Miller, Martin R.
Publicado: (2012)

Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
por: Lin, Ling, et al.
Publicado: (2023)

Absence of airflow obstruction on spirometry: can it still be COPD?
por: Neder, José Alberto, et al.
Publicado: (2020)

Current situation of asthma–COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study
por: Kang, Jian, et al.
Publicado: (2020)

Association of incidental emphysema with annual lung function decline and future development of airflow limitation
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2016)

Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?
por: Nishimura, Koichi, et al.
Publicado: (2011)

Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
por: Harries, Timothy H, et al.
Publicado: (2019)

Effects of Air Pollutant Exposure on Exacerbation Severity in Asthma Patients with or without Reversible Airflow Obstruction
por: Fang, Wei, et al.
Publicado: (2021)

Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective cohort study
por: Song, Qing, et al.
Publicado: (2023)

Impact of airflow limitation in chronic heart failure
por: Bektas, S., et al.
Publicado: (2017)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

3D-measurement of tracheobronchial angles on inspiratory and expiratory chest CT in COPD: respiratory changes and correlation with airflow limitation
por: Onoe, Rintaro, et al.
Publicado: (2018)

Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD
por: Foda, Hussein D, et al.
Publicado: (2017)

Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients
por: Løkke, Anders, et al.
Publicado: (2022)

Prediction of gold stage in patients hospitalized with COPD exacerbations using blood neutrophils and demographic parameters as risk factors
por: Chen, Jing, et al.
Publicado: (2021)

The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease
por: Lin, Ling, et al.
Publicado: (2023)

Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study
por: Montes de Oca, Maria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ubm0scruhf967idukaftihpums